WeVote
Log In

Bill

Bill

HB 5279

AN ACT CONCERNING HEALTH INSURANCE COVERAGE FOR INSULIN.

2025 Regular Session Introduced by Gary Turco

Connecticut bill regulating health insurance coverage for insulin to improve patient access and reduce out-of-pocket medication costs for diabetics.

REF. TO JOINT COMM. ON Insurance and Real Estate
#healthinsurance #medicine
0
WeVote Research Nonpartisan
Bill Summary · HB 5279

Legislative bill overview

HB 5279 proposes to regulate health insurance coverage for insulin in Connecticut, likely addressing affordability and access to this critical medication for diabetic patients. The bill has been referred to the Joint Committee on Insurance and Real Estate for review. Specific provisions are not yet detailed in available records, but the bill title indicates it targets insurance coverage requirements or cost-sharing restrictions related to insulin.

Why is this important

Insulin is an essential, life-sustaining medication for millions of Americans with diabetes, yet high out-of-pocket costs have forced many patients to ration doses or skip medications entirely—creating serious health risks. Connecticut legislation in this area could establish state-level protections on insulin copays, deductibles, or coverage requirements, potentially serving as a model for other states. This directly affects the healthcare accessibility and financial burden of Connecticut residents managing diabetes.

Potential points of contention

  • Insurance industry costs: Mandating broader insulin coverage or lower cost-sharing may increase insurance premiums for all enrollees, raising concerns about whether costs are shifted rather than reduced
  • Scope of coverage: Disagreement over which insulin formulations should be covered, whether older generic insulins should be prioritized first, and how to balance access with cost-containment strategies
  • Implementation burden: Health insurers and employers may argue that specific coverage mandates create administrative complexity and difficulty in negotiating pharmaceutical pricing

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.